ผู้เขียน: admin
-
Laboratoires Pierre Fabre receives European Commission Approval for BRAFTOVI® (encorafenib) in combination with cetuximab and FOLFOX (fluorouracil, leucovorin, and oxaliplatin) for the first-line treatment of adult patients with BRAFV600E-mutant metastatic colorectal cancer (mCRC)
European approval is based on results from the Phase 3 …
-
NYSE Content Update: Cannes Lions International Festival of Creativity Begins
NYSE issues a pre-market daily advisory direct from the…
-
Smart Weigh Brings Automated Weighing and Packing into a Single Workflow for Ready Meal Manufacturers
Integrated solutions combine weighing, filling and pack…
-
Supermicro Delivers NVIDIA Vera Rubin NVL4 End-to-End DCBBS Blueprint with Native FP64 Performance for Converged HPC and AI Infrastructure
Total solution includes up to 1,152 NVIDIA Rubin GPUs a…
-
Block Reign Announces Completion of CertiK Review of Gnodi Blockchain
Completed independent review reflects a proactive commi…
-
MDJM LTD Confirms Its Securities Are Quoted on the OTCQB Venture Market
LETHAM, Scotland, June 22, 2026 /PRNewswire/ — MDJM Lt…
-
VDEAR Supports the Growth of Global Watch Micro-brands Through End-to-End OEM/ODM Manufacturing
SHENZHEN, China, June 22, 2026 /PRNewswire/ — While th…
-
Ecosolex to Showcase Full-Scenario C&I and Residential Energy Storage at ees Europe 2026, Backed by Local European Delivery and Service
MUNICH, June 22, 2026 /PRNewswire/ — Ecosolex, the ene…
-
Cheche Group Launches “ABAO Agent,” an AI-Powered Intelligent Underwriting Solution
BEIJING, June 22, 2026 /PRNewswire/ — Cheche Group Inc…
-
WiMi Hologram Cloud Inc. Researches Synergic Quantum Generative Network Architecture
BEIJING, June 22, 2026 /PRNewswire/ — WiMi Hologram Cl…